Literature DB >> 10470581

Pathophysiologic correlates of hypocholesterolemia in critically ill surgical patients.

I Giovannini1, G Boldrini, C Chiarla, F Giuliante, M Vellone, G Nuzzo.   

Abstract

OBJECTIVE: To assess correlates of hypocholesterolemia in moderate to critical surgical illness.
DESIGN: Prospective analysis of laboratory and clinical data.
SETTING: Department of surgery in a university hospital. PATIENTS: 135 patients undergoing uncomplicated abdominal surgery or with sepsis, liver failure, hemorrhage, severe cholestasis, or multiple organ dysfunction syndrome (MODS).
INTERVENTIONS: Surgical and/or medical therapy according to clinical status.
MEASUREMENTS AND MAIN RESULTS: Determinations of total cholesterol, additional variables, and clinical data. Cholesterol decreased after surgery, in sepsis, liver failure, acute hemorrhage, and MODS and increased in cholestasis. Hypocholesterolemia correlated with decreases in plasma proteins and indices of hepatic protein synthetic adequacy, with hemodilution from blood loss, and was moderated or prevented by cholestasis.
CONCLUSIONS: These results help to explain the dynamics of the development, clinical relevance, and negative prognostic value of hypocholesterolemia in critical illness.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10470581     DOI: 10.1007/s001340050940

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  17 in total

1.  Plasma cholesterol level after hepatopancreatobiliary surgery provides information on the postoperative clinical course.

Authors:  Gennaro Nuzzo; Ivo Giovannini
Journal:  Updates Surg       Date:  2010-09-07

2.  Body mass index interaction effects with hyperglycemia and hypocholesterolemia modify blunt traumatic brain injury outcomes: a retrospective study.

Authors:  Gregory S Huang; Carl M Dunham; Elisha A Chance; Barbara M Hileman; Daniel J DelloStritto
Journal:  Int J Burns Trauma       Date:  2020-12-15

3.  Reappraisal of plasmapheresis as a supportive measure in a patient with hepatic failure after major hepatectomy.

Authors:  Shin Hwang; Tae-Yong Ha; Chul-Soo Ahn; Ki-Hun Kim; Sung-Gyu Lee
Journal:  Case Rep Gastroenterol       Date:  2007-12-21

4.  Cholesterol improves the utilization of parenteral lipid emulsions.

Authors:  Wilfred Druml; Margot Fischer
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 1.704

5.  Cholesterol metabolism in acute upper gastrointestinal bleeding, preliminary observations.

Authors:  Vladimír Hrabovský; Alice Mendlová; Zdeněk Zadák; Vladimír Bláha; Radomír Hyšpler; Alena Tichá; Zdeněk Svagera
Journal:  Wien Klin Wochenschr       Date:  2012-11-20       Impact factor: 1.704

Review 6.  Clinical potential of insulin therapy in critically ill patients.

Authors:  Dieter Mesotten; Greet Van den Berghe
Journal:  Drugs       Date:  2003       Impact factor: 9.546

7.  Therapeutic plasma exchange as an effective salvage measure for post-hepatectomy hepatic failure: A case report.

Authors:  Lee Na Ryu; Shin Hwang; Suhyeon Ha
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-05-31

8.  Liver X receptor α activation with the synthetic ligand T0901317 reduces lung injury and inflammation after hemorrhage and resuscitation via inhibition of the nuclear factor κB pathway.

Authors:  Patrick D Solan; Giovanna Piraino; Paul W Hake; Alvin Denenberg; Michael O'Connor; Alex Lentsch; Basilia Zingarelli
Journal:  Shock       Date:  2011-04       Impact factor: 3.454

9.  Major Lipids and Future Risk of Pneumonia: 20-Year Observation of the Atherosclerosis Risk in Communities (ARIC) Study Cohort.

Authors:  Sangmee Sharon Bae; L Cindy Chang; Sharon Stein Merkin; David Elashoff; Junichi Ishigami; Kunihiro Matsushita; Christina Charles-Schoeman
Journal:  Am J Med       Date:  2020-08-16       Impact factor: 4.965

10.  Changes in cholesterol and its precursors during the first days after major trauma.

Authors:  Bohumil Bakalar; Radovan Hyspler; Jan Pachl; Zdenek Zadak
Journal:  Wien Klin Wochenschr       Date:  2003-11-28       Impact factor: 2.275

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.